ABC30.comFDA chief defends new pain drug despite worries about abuseReutersWASHINGTON (Reuters) – The head of the Food and Drug Administration on Thursday defended the agency’s approval of Zohydro, a powerful prescription opioid made by Zogenix Inc, saying it offers a “unique” option to treat pain despite concerns about …FDA official catches more heat over OK of painkiller ZohydroMilwaukee Journal SentinelPossible Zohydro competitor surfacesMedical Marketing and MediaWest Virginia lawmaker proposes ban on ZohydroSan Antonio ExpressBoston Heraldall 226 news articles …read more
Via: Google USA
FDA chief defends new pain drug despite worries about abuse - Reuters
Real Estate of Cebu
